Wednesday, April 20, 2011 11:33:27 AM
The 'value' of the company changed on a continuous basis depending on the story being told at the time. When DNAG rolled out their association with Dutchess they told everyone that they were going to get $25 million dollars of financing and they were going to purchase 51% of Biofrontera, establishing the 'value' of the company at over $50 million. Later on (not long after) they purchased 18% for $1.9 million, presumably after doing something else with the rest of the $25 million. 18% at $1.9 million puts a 'value' of around $10.5 million.
The reality was that there was no $25 million it was just a story to 'sell' the association of the company with a toxic death spiral financier. Additionally Biofrontera was a convenient foil to spin stories with while the company printed and sold shares, which was their only real source of income. There was no viable technology and there was no viable revenues, just window dressing for selling shares. Once the shares were gone and the pps was worthless the principles walked away with their 'salaries' and left the dregs to be fought over by the remaining investors and all the creditors, including Dutchess who in the end got reamed as well.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM